Open access

Second-Line Chemotherapy for Platinum- and Taxane-Resistant Epithelial Ovarian Cancer: Pegylated Liposomal Doxorubicin (PLD), Irinotecan, and Combination Therapies at Lower Doses

Written By

Toru Sugiyama

Submitted: 01 March 2011 Published: 15 February 2012

DOI: 10.5772/28554

From the Edited Volume

Ovarian Cancer - Clinical and Therapeutic Perspectives

Edited by Samir A. Farghaly

Chapter metrics overview

1,923 Chapter Downloads

View Full Metrics

Written By

Toru Sugiyama

Submitted: 01 March 2011 Published: 15 February 2012